HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $26,000 | -70.1% | 104,750 | -61.5% | 0.00% | – |
Q3 2014 | $87,000 | +1.2% | 271,800 | -2.5% | 0.00% | – |
Q2 2014 | $86,000 | -25.2% | 278,900 | -3.2% | 0.00% | – |
Q1 2014 | $115,000 | +51.3% | 288,100 | 0.0% | 0.00% | – |
Q4 2013 | $76,000 | +11.8% | 288,100 | 0.0% | 0.00% | – |
Q3 2013 | $68,000 | +4.6% | 288,100 | -1.1% | 0.00% | – |
Q2 2013 | $65,000 | – | 291,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Occidental Asset Management, LLC | 190,000 | $521,000 | 0.65% |
WEDBUSH SECURITIES INC | 80,000 | $18,000 | 0.00% |
CITY HOLDING CO | 5,000 | $1,000 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 290,000 | $66,120,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 20,792 | $4,000 | 0.00% |
NORTHERN TRUST CORP | 235,051 | $53,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 897,977 | $204,000 | 0.00% |
STATE STREET CORP | 81,000 | $18,000 | 0.00% |
GUGGENHEIM CAPITAL LLC | 37,501 | $9,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 24,735 | $6,000 | 0.00% |